Advertisement

Topics

Companies Related to "FEDRATINIB Best Available Therapy Primary Myelofibrosis∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

18:00 EDT 15th July 2019 | BioPortfolio

Here are the most relevant search results for "FEDRATINIB Best Available Therapy Primary Myelofibrosis∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "FEDRATINIB Best Available Therapy Primary Myelofibrosis derfield score" Companies 1–25 of 2,100+

Thursday 11th July 2019

Medical Economics®

Medical Economics® is a digital and print multimedia platform that provides physicians with expert advice, shared experiences, tools and resources to succeed in today’s practice environment. As the highest-ranked practice management publication in the market, Medical Economics® covers topics including primary care, the business of medicine, heal...


Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...

Tuesday 9th July 2019

Dermatology Times®

A multimedia platform for dermatologists, Dermatology Times® provides regulatory and clinical updates, as well as discussion on cost-effective practice management solutions. Dermatology Times® helps dermatology professionals grow their knowledge and advance their practice to improve patient care by providing them with the latest news and trends in dermatologic procedures, therapy, technolog...


Monday 8th July 2019

ATI Physical Therapy

ATI is a privately held, nationally recognized healthcare company, specializing in outpatient rehabilitation and adjacent healthcare services. With a focus on delivering a remarkable experience to every patient, every day, ATI has more than 800 locations from coast to coast. ATI was named “Best Physical Therapy Practice in the Nation” by ADVANCE magazine and was one of the first physica...

AHMC Healthcare Inc.

AHMC Healthcare Inc., operating six acute care hospitals in Southern California having 1,102 total beds and over 6,000 employees, has established itself as a healthcare provider offering a wide range of services from primary to tertiary care. Attracting the most qualified and dedicated staff, AHMC Healthcare Inc. and its affiliated hospitals are recognized...

Monday 1st July 2019

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com

Friday 28th June 2019

Promedica International

Promedica International is a provider of CRO services to themedical device, biotech and pharmaceutical industries. Specializing in projectsinvolving innovative technology, our experienced staff and ISO-certified processesare the primary factors enabling us to consistently provide services highly regarded by our clients and their related study teams

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Wednesday 26th June 2019

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...

Tuesday 25th June 2019

California Protons Cancer Therapy Center

California Protons’ intensity-modulated pencil beam scanning technology is a highly precise form of cancer radiation treatment that enables doctors to selectively target tumors with high-dose radiation while sparing healthy tissue. California Protons’ pencil beam scanning technology precisely delivers proton radiation treatment within 2 millimete...

Innovest Global, Inc.

Innovest Global, Inc. (OTC Markets: IVST) has operations in industrials (commercial and industrial products and services, energy, construction, and building materials) and investments in biotechnology. Our primary growth strategy is to acquire existing companies in a select few industries and attract new customers in cost effective ways.

Tuesday 18th June 2019

F-star Therapeutics Ltd.

F-star is a leading clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumour immune evasion, the Company’s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary te...

Monday 17th June 2019

IVERIC bio, Inc.

IVERIC bio is a biotechnology company with a focus on the discovery and development of novel gene therapy solutions to treat orphan inherited retinal diseases with unmet medical needs. Vision is Our Mission. For more information on the Company’s gene therapy and other programs, please visit www.ivericbio.com.

Mycovia Pharmaceuticals, Inc

Mycovia Pharmaceuticals has a passion for developing breakthrough therapies in areas of unmet medical need. Our lead product candidate, VT-1161 (oteseconazole), is a novel, oral therapy designed to have greater selectivity, fewer side effects and improved potency than current treatment options. It received FDA Qualified Infectious Disease Product and Fast-...

Friday 14th June 2019

CHI St. Vincent

CHI St. Vincent is a regional health network serving Arkansas since 1888 with a history of many firsts. Headquartered in Little Rock, our network includes primary care, specialty clinics, urgent care, hospitals, home health, rehabilitation and surgery centers across the state. It is also part of CommonSpirit Health, a nonprofit, Catholic health system dedi...

Wednesday 12th June 2019

IMV IMV Inc.

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a ...

Tuesday 11th June 2019

AlloVir

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s...

Monday 10th June 2019

OrthoTrophix, Inc.

OrthoTrophix, Inc., based in Oakland, California, is a privately held biopharmaceutical company focused on the development and commercialization of revolutionary therapeutics for the treatment of diseases and conditions involving the hard tissues. Founded by three co-founders in 2011, the primary focus of OrthoTrophix has been regeneration and repair of ca...

Wednesday 5th June 2019

OncoMyx Therapeutics

OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effecti...

Enzyvant

Enzyvant, a wholly owned subsidiary of Roivant Sciences, is a biotechnology company focused on developing transformative therapies for patients with rare diseases. Enzyvant leverages the Roivant platform to develop therapies that address high unmet medical needs while driving greater efficiency in research, clinical development, and commercialization. The ...

Tuesday 4th June 2019

Prevail Therapeutics Inc.

Prevail Therapeutics is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Prevail was founded by Dr. Abeliovich in 2017, through a collaborative effort with The Silverstein Foundation for Parkinson’s ...

Thursday 30th May 2019

4D Molecular Therapeutics, Inc.

4DMT is focused on the discovery and development of targeted, customized and proprietary next-generation AAV gene therapy products for use in patients with severe genetic diseases with high unmet medical need. 4DMT’s robust discovery platform, termed Therapeutic Vector Evolution, empowers it to create customized gene delivery vehicles that can be desi...

Cigna Corporation and Santa Clara County IPA (SCCIPA)

Santa Clara County IPA (SCCIPA) has been providing exceptional healthcare services for more than 30 years. More than 240 primary care physicians and 600 specialists are focused on delivering the highest quality of care, while driving lower cost of care for more than 90,000 members of major HMOs, PPOs, ACOs and Medicare Advantage programs. SCCIPA’s mis...

Wednesday 22nd May 2019

ElevateBio, LLC

ElevateBio, LLC, is a Cambridge-based biotechnology company, established to create and operate a broad portfolio of cell and gene therapy companies with leading academic researchers, medical centers and entrepreneurs. ElevateBio builds single- and multi-product companies by providing scientific founders with fully-integrated bench-to-bedside capabilities i...

Monday 20th May 2019

Galt Medical Corp.

Galt Medical Corp. has been a leading provider of vascular and interventional medical devices for almost 30 years, developing and manufacturing a range of products for interventional procedures. Galt offers a wide range of products, including private label products for medical device OEMs and Galt branded products to clinicians worldwide through a network ...


More From BioPortfolio on "FEDRATINIB Best Available Therapy Primary Myelofibrosis∨derfield=score∨derval=DESC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks